Made Scientific, NJIT partner to enhance graduate-level cell and gene therapy bioprocessing curriculum

Made Scientific Inc., a clinical- and commercial-stage cell therapy contract development and manufacturing organization, and New Jersey Institute of Technology announced a partnership to co-develop and deliver graduate-level bioprocessing elective courses within NJIT’s master of science program in chemical and materials engineering program.

Under this collaboration, Made Scientific will leverage its expertise in advanced therapies and bioprocessing — along with its Made Scientific Foundry scholar program, the academic pillar of Made Scientific’s workforce development and training offering — to support the creation of industry-aligned curriculum.

The scholar program is designed to prepare the next generation of cell and gene therapy professionals. It combines academic rigor with practical, hands-on experience grounded in the same standards, tools, and workflows used in cell and gene therapy manufacturing environments.

Launching Spring 2027, the course will equip graduate students with the skills and real-world knowledge required to make an immediate impact in the biotech industry.

“By combining Made Scientific’s hands-on manufacturing expertise and our workforce development & training program with NJIT‘s academic excellence, we are creating a truly differentiated learning experience — one that will produce industry-ready professionals capable of driving innovation in CGT manufacturing,” said Syed T. Husain, chairman and CEO of Made Scientific.

Today’s announcement marks the continuation of a long-standing partnership between the two organizations. Originating from NJIT’s New Jersey Innovation Institute (NJII), Made Scientific exemplifies the transformative impact that strong collaboration between higher education and industry can have on innovation and economic growth.

“This partnership brings industry-leading CGT expertise into our graduate curriculum in a way that is immersive, practical, and immediately relevant,” said Moshe Kam, dean of NJIT’s Newark College of Engineering. “Together, we grow and strengthen the advanced therapies workforce and support New Jersey’s position as a global leader in biomanufacturing.”

Read the full story on ROI-NJ here.